trazodone has been researched along with Astasia-Abasia in 2 studies
Trazodone: A serotonin uptake inhibitor that is used as an antidepressive agent. It has been shown to be effective in patients with major depressive disorders and other subsets of depressive disorders. It is generally more useful in depressive disorders associated with insomnia and anxiety. This drug does not aggravate psychotic symptoms in patients with schizophrenia or schizoaffective disorders. (From AMA Drug Evaluations Annual, 1994, p309)
trazodone : An N-arylpiperazine in which one nitrogen is substituted by a 3-chlorophenyl group, while the other is substituted by a 3-(3-oxo[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl)propyl group.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wald, J | 1 |
Taylor, S | 1 |
Scamvougeras, A | 1 |
Citarella, S | 1 |
Lieto, L | 1 |
Serio, E | 1 |
1 trial available for trazodone and Astasia-Abasia
Article | Year |
---|---|
[Clinical contribution to the study on the effects of trazodone in conversion hysteria].
Topics: Adolescent; Adult; Clinical Trials as Topic; Conversion Disorder; Drug Evaluation; Female; Humans; M | 1977 |
1 other study available for trazodone and Astasia-Abasia
Article | Year |
---|---|
Cognitive behavioural and neuropsychiatric treatment of post-traumatic conversion disorder: a case study.
Topics: Adaptation, Psychological; Adult; Cognitive Behavioral Therapy; Conversion Disorder; Diagnostic and | 2004 |